Literature DB >> 17105463

Neuropsychological findings: myoclonic astatic epilepsy (MAE) and Lennox-Gastaut syndrome (LGS).

Melissa Filippini1, Antonella Boni, Gloria Dazzani, Angelo Guerra, Giuseppe Gobbi.   

Abstract

PURPOSE: To identify a specific neuropsychological profile associated with myoclonic astatic epilepsy (MAE) and Lennox-Gastaut syndrome (LGS).
METHODS: Seven patients diagnosed with MAE and four patients diagnosed with LGS were selected from patients referred to our Child Neurology Unit. The patients were assessed both clinically (awake, sleep, Holter EEG, seizures frequency, and semiology) and neuropsychologically (IQ, language, attention, visuospatial and visuomotor abilities, and behavior). One representative case of each syndrome is presented here.
RESULTS: The clinical picture of the MAE patient resembled that of an MAE condition associated with transitory epileptic encephalopathy. The neuropsychological findings suggest that electroclinical anomalies can temporarily affect cognitive and behavioral functioning. Early effective antiepileptic drug (AED) treatment was found to improve cognitive outcome. In contrast, LGS was associated with mental retardation, which persisted after seizure control.
CONCLUSIONS: At present, it remains difficult to delineate a precise neuropsychological profile associated with MAE and LGS. The cognitive outcome of MAE is variable and depends on the clinical pattern. With regard to LGS, the hypothesis of a genetic predisposition underlying both the epilepsy and the mental retardation is still valid. Alternatively, exposure to subclinical electrophysiological anomalies during a critical period of cerebral development may be responsible for the mental retardation. At the time the clinical manifestations appear, drug treatment, even if effective, would have only limited impact on cognitive outcome. However, early multidisciplinary intervention may help to improve behavior and communicative abilities, enhancing the quality of life of these children and their families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105463     DOI: 10.1111/j.1528-1167.2006.00691.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

Review 1.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

Review 2.  Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.

Authors:  Markus von Deimling; Ingo Helbig; Eric D Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

3.  "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.

Authors:  Pasquale Parisi; Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Alberto Verrotti; Paola Iannetti; Maria Pia Villa
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

4.  Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.

Authors:  Krista Eschbach; Angela Moss; Charuta Joshi; Katie Angione; Garnett Smith; Amanda Dempsey; Elizabeth Juarez-Colunga; Scott T Demarest
Journal:  Epilepsy Res       Date:  2018-09-24       Impact factor: 3.045

5.  Epileptic encephalopathies in adults and childhood.

Authors:  Zekiye Kural; Ali Fahir Ozer
Journal:  Epilepsy Res Treat       Date:  2012-09-27

Review 6.  Dravet Syndrome: An Overview.

Authors:  Arsalan Anwar; Sidra Saleem; Urvish K Patel; Kogulavadanan Arumaithurai; Preeti Malik
Journal:  Cureus       Date:  2019-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.